Annual Interest Expense
$31.84 M
+$13.66 M+75.13%
December 31, 2023
Summary
- As of February 7, 2025, INBX annual interest expense is $31.84 million, with the most recent change of +$13.66 million (+75.13%) on December 31, 2023.
- During the last 3 years, INBX annual interest expense has risen by +$21.02 million (+194.38%).
- INBX annual interest expense is now at all-time high.
Performance
INBX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$0.00
-$5.36 M-100.00%
September 30, 2024
Summary
- As of February 7, 2025, INBX quarterly interest expense is $0.00, with the most recent change of -$5.36 million (-100.00%) on September 30, 2024.
- Over the past year, INBX quarterly interest expense has dropped by -$5.36 million (-100.00%).
- INBX quarterly interest expense is now -100.00% below its all-time high of $8.15 million, reached on September 30, 2023.
Performance
INBX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$5.36 M
-$8.15 M-60.32%
September 30, 2024
Summary
- As of February 7, 2025, INBX TTM interest expense is $5.36 million, with the most recent change of -$8.15 million (-60.32%) on September 30, 2024.
- Over the past year, INBX TTM interest expense has dropped by -$8.15 million (-60.32%).
- INBX TTM interest expense is now -82.56% below its all-time high of $30.73 million, reached on September 30, 2023.
Performance
INBX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
INBX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +75.1% | -100.0% | -60.3% |
| 3 y3 years | +194.4% | -100.0% | -77.1% |
| 5 y5 years | +2051.3% | -100.0% | -77.1% |
INBX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +510.4% | -100.0% | at low | -82.6% | +2.8% |
| 5 y | 5-year | at high | +510.4% | -100.0% | at low | -82.6% | +35.1% |
| alltime | all time | at high | +2051.3% | -100.0% | at low | -82.6% | +1088.7% |
Inhibrx Biosciences Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $5.36 M(-60.3%) |
| Jun 2024 | - | $5.36 M(-34.2%) | $13.51 M(-56.0%) |
| Dec 2023 | $31.84 M(+75.1%) | - | - |
| Sep 2023 | - | $8.15 M(+3.1%) | $30.73 M(+9.3%) |
| Jun 2023 | - | $7.91 M(+4.5%) | $28.13 M(+20.1%) |
| Mar 2023 | - | $7.56 M(+6.3%) | $23.43 M(+29.2%) |
| Dec 2022 | $18.18 M(+248.6%) | $7.11 M(+28.2%) | $18.14 M(+41.7%) |
| Sep 2022 | - | $5.55 M(+73.2%) | $12.80 M(+41.7%) |
| Jun 2022 | - | $3.20 M(+40.8%) | $9.03 M(+33.9%) |
| Mar 2022 | - | $2.27 M(+27.8%) | $6.75 M(+29.3%) |
| Dec 2021 | $5.22 M | $1.78 M(+0.1%) | $5.22 M(+31.4%) |
| Sep 2021 | - | $1.78 M(+94.5%) | $3.97 M(-40.0%) |
| Jun 2021 | - | $914.00 K(+22.7%) | $6.62 M(-27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $745.00 K(+40.0%) | $9.11 M(-15.8%) |
| Dec 2020 | $10.82 M(+89.1%) | $532.00 K(-88.0%) | $10.82 M(-14.1%) |
| Sep 2020 | - | $4.43 M(+30.0%) | $12.60 M(+16.2%) |
| Jun 2020 | - | $3.40 M(+38.9%) | $10.84 M(+36.8%) |
| Mar 2020 | - | $2.45 M(+6.0%) | $7.92 M(+38.5%) |
| Dec 2019 | $5.72 M(+286.4%) | $2.31 M(-13.4%) | $5.72 M(+67.9%) |
| Sep 2019 | - | $2.67 M(+444.9%) | $3.41 M(+362.3%) |
| Jun 2019 | - | $490.00 K(+98.4%) | $737.00 K(+16.1%) |
| Mar 2019 | - | $247.00 K(-36.3%) | $635.00 K(-24.3%) |
| Dec 2018 | $1.48 M(-30.4%) | - | - |
| Jun 2018 | - | $388.00 K(-14.0%) | $839.00 K(+86.0%) |
| Mar 2018 | - | $451.00 K | $451.00 K |
| Dec 2017 | $2.13 M | - | - |
FAQ
- What is Inhibrx Biosciences annual interest expense?
- What is the all time high annual interest expense for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual interest expense year-on-year change?
- What is Inhibrx Biosciences quarterly interest expense?
- What is the all time high quarterly interest expense for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly interest expense year-on-year change?
- What is Inhibrx Biosciences TTM interest expense?
- What is the all time high TTM interest expense for Inhibrx Biosciences?
- What is Inhibrx Biosciences TTM interest expense year-on-year change?
What is Inhibrx Biosciences annual interest expense?
The current annual interest expense of INBX is $31.84 M
What is the all time high annual interest expense for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual interest expense is $31.84 M
What is Inhibrx Biosciences annual interest expense year-on-year change?
Over the past year, INBX annual interest expense has changed by +$13.66 M (+75.13%)
What is Inhibrx Biosciences quarterly interest expense?
The current quarterly interest expense of INBX is $0.00
What is the all time high quarterly interest expense for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly interest expense is $8.15 M
What is Inhibrx Biosciences quarterly interest expense year-on-year change?
Over the past year, INBX quarterly interest expense has changed by -$5.36 M (-100.00%)
What is Inhibrx Biosciences TTM interest expense?
The current TTM interest expense of INBX is $5.36 M
What is the all time high TTM interest expense for Inhibrx Biosciences?
Inhibrx Biosciences all-time high TTM interest expense is $30.73 M
What is Inhibrx Biosciences TTM interest expense year-on-year change?
Over the past year, INBX TTM interest expense has changed by -$8.15 M (-60.32%)